+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Diagnostics Market - Global Forecast 2026-2032- Product Image
Allergy Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Allergy Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905051
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Allergy Diagnostics Market is projected to reach USD 6.67 Billion in 2026. It is expected to continue growing at a CAGR of 6.61%, reaching USD 9.86 Billion by 2032.

The allergy diagnostics market is becoming a core pillar of precision medicine as allergic rhinitis, asthma, food allergy, atopic dermatitis, drug allergy, and insect venom hypersensitivity continue to rise worldwide. The World Allergy Organization reports that allergic diseases affect an estimated 10% to 40% of the global population, while the World Health Organization estimated 262 million people lived with asthma in 2019, underscoring sustained demand for accurate allergy testing and long-term disease management.

Clinical adoption is shifting from broad symptom-based assessment toward evidence-based diagnosis using skin prick testing, serum-specific IgE testing, component-resolved diagnostics, multiplex immunoassays, and digital decision support. For manufacturers, laboratories, health systems, and payers, growth is tied to faster turnaround times, validated biomarkers, guideline-aligned testing, and improved access across high-burden pediatric and adult populations.

Transformative Shifts in Allergy Diagnostics

The allergy diagnostics landscape is being reshaped by three major shifts: the move from extract-based testing to molecular allergy diagnostics, the expansion of automated immunoassay platforms, and the growing clinical expectation for test results that guide treatment decisions rather than simply confirm sensitization. Component-resolved diagnostics are especially important for differentiating genuine food allergy risk from cross-reactivity, which can help reduce unnecessary avoidance diets and improve allergen immunotherapy selection.

A second transformation is occurring in care delivery. Allergy testing is expanding beyond specialist clinics into hospital laboratories, primary care networks, retail-linked diagnostics, and telehealth-supported pathways. This trend is supported by increasing awareness of asthma-allergy comorbidity, food allergy safety, and the need for early diagnosis in children, but it also raises the bar for quality control, clinician education, and reimbursement clarity.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence allergy diagnostics through pattern recognition, clinical risk stratification, laboratory workflow optimization, and interpretation support for multiplex IgE panels. AI-enabled tools can help clinicians connect symptoms, exposure history, total IgE, specific IgE, eosinophil counts, spirometry, and comorbidity data to improve diagnostic confidence, particularly where specialist access is limited.

The cumulative impact of AI will depend on validation, explainability, and regulatory oversight. Industry leaders should prioritize clinically governed AI that improves sensitivity, specificity, and turnaround time without overdiagnosis. The strongest opportunities are expected in triage algorithms, automated assay quality monitoring, population-level allergy surveillance, and decision support for immunotherapy eligibility.

Key Regional Insights for Allergy Diagnostics

Asia-Pacific is one of the most dynamic regions for allergy diagnostics, supported by urbanization, air pollution exposure, rising middle-class healthcare spending, and expanding laboratory infrastructure in China, India, Japan, South Korea, and Australia. North America remains a high-value region driven by strong clinical awareness, established reimbursement pathways, regulated diagnostic innovation, and the documented allergy burden reported by the CDC, including seasonal and food allergies in children and adults.

Europe benefits from guideline-driven care, extensive specialist networks, and active research communities, particularly in Germany, France, Italy, Spain, and the United Kingdom. Latin America is advancing through private laboratory networks and growing asthma and rhinitis management programs, while the Middle East is seeing demand linked to dust exposure, indoor allergens, and investment in tertiary care. Africa remains underpenetrated, with progress dependent on affordable testing, workforce training, and integration with respiratory disease programs.

Key Group Insights Across Major Economic Blocs

ASEAN markets are gaining relevance as expanding urban populations and private diagnostic chains increase access to allergy testing, although affordability and specialist availability remain uneven. GCC countries are investing in advanced hospital systems and laboratory automation, creating demand for high-throughput immunoassay platforms and allergy panels suited to indoor, dust mite, mold, and environmental allergen profiles.

The European Union is defined by harmonized regulatory expectations, strong evidence standards, and growing adoption of molecular diagnostics. BRICS countries represent scale-driven opportunity, with China, India, and Brazil expanding diagnostic capacity while Russia and South Africa face access and infrastructure variability. G7 markets continue to lead in innovation, reimbursement sophistication, and clinical guideline adoption, while NATO member countries collectively emphasize resilient healthcare supply chains and standardized laboratory quality systems.

Key Country Insights in Allergy Diagnostics

The United States leads in allergy diagnostics innovation through advanced laboratory networks, broad use of serum-specific IgE testing, and strong adoption of specialty allergy care, while Canada emphasizes guideline-based care and equitable access through provincial systems. Mexico and Brazil show rising demand through private laboratories and respiratory allergy management, with Brazil offering notable scale in Latin America. The United Kingdom, Germany, France, Italy, and Spain benefit from mature healthcare systems, European allergy research leadership, and growing use of component-resolved diagnostics.

Russia presents a mixed environment shaped by centralized healthcare capacity and regional access gaps. China and India are high-growth markets due to large patient populations, urban air quality concerns, and expanding diagnostic infrastructure, while Japan and South Korea are advanced markets with strong technology adoption and high-quality laboratory standards. Australia demonstrates sophisticated allergy and immunology practice, particularly in food allergy research, pediatric allergy care, and evidence-based testing pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated test menus that align with WAO, EAACI, AAAAI, and national allergy guidelines. Investment should focus on molecular allergy diagnostics, automated immunoassays, pediatric-friendly sampling, and digital interpretation tools that reduce false positives and support better clinical decisions.

Commercial teams should build region-specific access strategies, including reimbursement evidence in mature regions and affordability models in emerging regions. Partnerships with hospitals, reference laboratories, asthma programs, and primary care networks can expand testing adoption, while education for clinicians and patients can reduce misdiagnosis and inappropriate allergen avoidance.

Research Methodology

This executive summary is based on secondary research from verified public-health, regulatory, and clinical sources, including the World Health Organization, World Allergy Organization, CDC, NIH/NIAID, EAACI, AAAAI, FDA, EMA, and peer-reviewed allergy and immunology literature. The analysis emphasizes epidemiology, diagnostic pathways, technology adoption, reimbursement context, and regional healthcare infrastructure.

A structured triangulation approach compares disease-burden indicators, regulatory developments, laboratory adoption patterns, industry activity, and clinical guideline trends. Insights are reviewed for consistency, relevance, and applicability to support executive decision-making in allergy diagnostics.

Conclusion

Allergy diagnostics is moving from a supporting role in allergy care to a strategic enabler of precision medicine, preventive health, and targeted therapy. Rising global allergy prevalence, improved awareness of food and respiratory allergies, and expanding access to immunoassay and molecular testing are creating durable demand for accurate and clinically useful testing.

The next phase of leadership will belong to organizations that combine analytical accuracy, clinical utility, automation, AI-enabled interpretation, and equitable access. Providers that deliver reliable, guideline-aligned, and regionally relevant allergy testing solutions will be best positioned for long-term growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Allergy Diagnostics Market, by Test Type
7.1. Introduction
7.2. Intradermal Test
7.3. Patch Test
7.4. Serum-Specific IgE Test
7.4.1. Chemiluminescence Immunoassay
7.4.2. Enzyme-Linked Immunosorbent Assay
7.4.3. Radioallergosorbent Test
7.5. Skin Prick Test
8. Allergy Diagnostics Market, by Technology
8.1. Introduction
8.2. Chemiluminescence Immunoassay
8.3. Enzyme-Linked Immunosorbent Assay
8.4. Fluorescent Enzyme Immunoassay
8.5. Radioallergosorbent Test
9. Allergy Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Skin
9.4. Saliva
9.5. Nasal Fluids
10. Allergy Diagnostics Market, by Allergen Type
10.1. Introduction
10.2. Contact Allergen
10.3. Drug Allergen
10.4. Food Allergen
10.5. Inhalant Allergen
11. Allergy Diagnostics Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Diagnostic Laboratories
11.4. Hospitals & Clinics
12. Allergy Diagnostics Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Allergy Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Allergy Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. ALK-Abelló A/S
16.3. Allergy Therapeutics PLC
16.4. Astra Biotech GmbH
16.5. Bausch & Lomb Incorporated
16.6. Biomérieux SA
16.7. Danaher Corporation
16.8. Dr. Fooke-Achterrath Laboratorien GmbH
16.9. DST Diagnostische Systeme & Technologien GmbH
16.10. Erba Group
16.11. Eurofins Scientific
16.12. F. Hoffmann-La Roche Ltd
16.13. HAL Allergy B.V.
16.14. Hitachi, Ltd.
16.15. HOB Biotech Group Corp., Ltd.
16.16. HollisterStier by Jubilant Life Sciences Limited
16.17. HYCOR Biomedical
16.18. Lincoln Diagnostics, Inc.
16.19. Minaris Medical America, Inc.
16.20. Neogen Corporation
16.21. Omega Diagnostics Group PLC
16.22. Parkway Pantai Ltd.
16.23. Quest Diagnostics Incorporated
16.24. R-Biopharm AG
16.25. Romer Labs Division Holding GmbH by Royal DSM
16.26. Siemens AG
16.27. Stallergenes Greer International AG
16.28. Tecan Trading AG
16.29. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL ALLERGY DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ALLERGY DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ALLERGY DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ALLERGY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INTRADERMAL TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INTRADERMAL TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INTRADERMAL TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL PATCH TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL PATCH TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL PATCH TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SERUM-SPECIFIC IGE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SERUM-SPECIFIC IGE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SERUM-SPECIFIC IGE TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SKIN PRICK TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SKIN PRICK TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SKIN PRICK TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FLUORESCENT ENZYME IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FLUORESCENT ENZYME IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL FLUORESCENT ENZYME IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL RADIOALLERGOSORBENT TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SKIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SKIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SKIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NASAL FLUIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NASAL FLUIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NASAL FLUIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CONTACT ALLERGEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CONTACT ALLERGEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CONTACT ALLERGEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG ALLERGEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG ALLERGEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG ALLERGEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FOOD ALLERGEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FOOD ALLERGEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL FOOD ALLERGEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL INHALANT ALLERGEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL INHALANT ALLERGEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL INHALANT ALLERGEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 82. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 84. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 91. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 92. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 93. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 94. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 98. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 99. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 100. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 101. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 102. EUROPE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 105. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 106. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 107. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 108. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 109. MIDDLE EAST ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 112. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 113. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 114. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 115. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 116. AFRICA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 120. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 121. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 122. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 123. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 124. ASEAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 125. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 127. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 128. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 129. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 130. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 131. GCC ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 141. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 142. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 143. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 144. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 145. BRICS ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 148. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 149. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 151. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 152. G7 ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 155. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 156. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 157. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 158. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 159. NATO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL ALLERGY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 161. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 162. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 163. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 164. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 165. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 166. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 167. UNITED STATES ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 169. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 170. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 171. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 173. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 174. CANADA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 176. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 177. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 178. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 180. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 181. MEXICO ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 184. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 185. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 187. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 188. BRAZIL ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 190. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 191. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 192. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 193. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 194. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 195. UNITED KINGDOM ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 197. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 198. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 199. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 200. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 201. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 202. GERMANY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 205. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 206. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 208. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 209. FRANCE ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 211. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 212. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 213. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 214. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 215. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 216. RUSSIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 219. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 220. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 221. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 222. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 223. ITALY ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 226. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 227. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 229. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 230. SPAIN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 233. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 234. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 235. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 236. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 237. CHINA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 240. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 241. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 243. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 244. INDIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 247. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 248. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 249. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 250. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 251. JAPAN ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 254. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 255. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 256. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 257. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 258. AUSTRALIA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 261. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY SERUM-SPECIFIC IGE TEST, 2017-2032 (USD MILLION)
TABLE 262. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 264. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY ALLERGEN TYPE, 2017-2032 (USD MILLION)
TABLE 265. SOUTH KOREA ALLERGY DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. GLOBAL ALLERGY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 267. GLOBAL ALLERGY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • ALK-Abelló A/S
  • Allergy Therapeutics PLC
  • Astra Biotech GmbH
  • Bausch & Lomb Incorporated
  • Biomérieux SA
  • Danaher Corporation
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • DST Diagnostische Systeme & Technologien GmbH
  • Erba Group
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • HAL Allergy B.V.
  • Hitachi, Ltd.
  • HOB Biotech Group Corp., Ltd.
  • HollisterStier by Jubilant Life Sciences Limited
  • HYCOR Biomedical
  • Lincoln Diagnostics, Inc.
  • Minaris Medical America, Inc.
  • Neogen Corporation
  • Omega Diagnostics Group PLC
  • Parkway Pantai Ltd.
  • Quest Diagnostics Incorporated
  • R-Biopharm AG
  • Romer Labs Division Holding GmbH by Royal DSM
  • Siemens AG
  • Stallergenes Greer International AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.67 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.86 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032 - Product Image

Food Allergy Diagnostics & Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Allergy Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - Global Forecast to 2031 - Product Image

Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - Global Forecast to 2031

  • Report
  • 257 Pages
  • Global
From
Allergy Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Allergy Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Allergy Diagnostics - Global Strategic Business Report - Product Image

Allergy Diagnostics - Global Strategic Business Report

  • Report
  • 638 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.